Plasma Exosome-Derived SENP1 May Be a Potential Prognostic Predictor for Melanoma

Abstract

Melanoma patients with higher plasma exosome-derived SENP1 levels had worse DFS and OS. The plasma exosome-derived SENP1 levels may be a potential prognostic predictor for 3-year DFS and 3-year OS of melanoma.